A. Gadre

Novel, potent, selective, and orally bioavailable human betaII-tryptase inhibitors.

M. Mcgrath, Rohan V Mendonca, J. Janc, 2006, Bioorganic & medicinal chemistry letters.

The synthesis, and dopamine D2 and serotonin 5-HT3 receptor affinity of 3-aza analogues (pyridyl) of 4-amino-5-chloro-2-methoxybenzamides

F. King, J. Jerman, M. Coldwell, 1995 .

Binding of Substituted Acetic Acids to α-Cyclodextrin in Aqueous Solution

K. A. Connors, A. Gadre, 1997 .

Binding of Cyclodextrins to Alicyclic and Aromatic Substrates: Complex Formation of α-, β-, and γ-Cyclodextrins with Substituted Cyclohexanecarboxylic Acids and Phenylalkanoic Acids

K. A. Connors, H. Schneider, V. Rüdiger, 1997 .

In vivo properties of SB 200646A, a 5‐HT2C/2B receptor antagonist

I. Forbes, T. Blackburn, G. Kennett, 1994, British journal of pharmacology.

Model studies on a synthetically facile series of N-substituted phenyl-N'-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT(2C/2B) receptor antagonists.

S. Bromidge, S. Dabbs, D. Davies, 1999, Bioorganic & medicinal chemistry.

N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea hydrochloride: the first selective 5-HT1C receptor antagonist.

P. Ham, G. Kennett, M. Wood, 1993, Journal of medicinal chemistry.